Since 1990, helping busy clinicians master the science and art of caring for people with HIV disease.

PRN Member Menu

Due to the COVID-19 pandemic, all meetings are now via the Zoom Webinar platform.
Register Here
MEETING AND CME INFORMATION

PRN Meeting: December 17, 2024 Jointly provided by the Medical Society of the State of New York, at a Zoom webinar, 7:00 p.m. to 9:00 p.m (EST).

Target Audience:

Physicians, Nurse Practitioners, and Physician Assistants caring for people at risk for, or infected with HIV and/or viral hepatitis.

Course Director: James F. Braun, DO, President & Program Planner, Physicians' Research Network

Moderator: Roy M. Gulick, MD, MPH, Rochelle Belfer Professor in Medicine / Chief, Division of Infectious Diseases / Attending Physician, NY Presbyterian Hospital

Guest Speakers and Presentations:

Highlights from the 2024 HIV Research for Prevention (R4P) Conference

Beatriz Grinsztejn, MD

President, International AIDS Society (IAS)
Head of the STD/AIDS Clinical Research Laboratory
Evandro Chagas National Institute of Infectious Diseases (FIOCRUZ)
Rio de Janeiro, Brasil

At the completion of this educational activity learners will:
1. Gain awareness of the most significant findings and innovations presented at the HIV R4P conference.
2. Understand the newest scientific discoveries from clinical trials and their implications for real-world HIV prevention.
3. Be able to explore strategies to address challenges limiting the wider adoption of HIV prevention interventions.
4. Assess how recent findings can enhance prevention programs in diverse settings and address ongoing gaps in HIV prevention efforts.

HIV Management: Where Are We Now? Where Are We Going?

Rajesh T. Gandhi, MD

Director, HIV Clinical Services and Education
Massachusetts General Hospital
Co-Director, Harvard Center for AIDS Research
Professor of Medicine, Harvard Medical School
Boston, MA

At the completion of this educational activity learners will:
1. Understand options for therapy for people with HIV, including the role of long-acting injectables.
2. Appreciate the approach to initiating or switching treatment in people with drug resistant HIV.
3. Be aware of recent advances in maintaining health in people with HIV.

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing Medical Education for physicians.

The Medical Society of the State of New York designates this live activity for a maximum 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement:

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statements:

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun (Course Director/Program Planner) has no relevant financial relationships to disclose.
- Dr. Roy M. Gulick, MD, MPH (Moderator) has no relevant financial relationships to disclose.
- Dr. Beatriz Grinsztejn, MD (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Advisory board member to Gilead, Merck and ViiV. Dr. Grinsztejn will submit her slides in advance for adequate peer review and will support her presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.
- Dr. Rajesh T. Gandhi, MD (Presenter) has no relevant financial relationships to disclose. Dr. Gandhi will submit his slides in advance for adequate peer review and will support his presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support:

This PRN CME activity is funded in part by unrestricted educational grants from Gilead Sciences and ViiV Healthcare and by a generous charitable contribution from Northwell Health Center for AIDS Research & Treatment.

PRN Member Menu

Are you a member? If so, please log-in.

Not a member? Please register.

Have you forgotten your password?